Celldex Therapeutics (CLDX) Tax Provisions (2017 - 2021)
Celldex Therapeutics (CLDX) recorded quarterly Tax Provisions of -$227000.0 in Q3 2021, down 125.22% quarter-over-quarter from $900000.0 in Q4 2020.
Celldex Therapeutics (CLDX) Tax Provisions (2017 - 2021) Analysis & Trends
Celldex Therapeutics' Tax Provisions history runs 4 years deep, the most recent figure standing at -$227000.0 for Q3 2021.
- In Q3 2021, Tax Provisions changed N/A year-over-year to -$227000.0; the TTM figure through Dec 2021 stood at $673000.0 (down 3.86% YoY), while the FY2021 annual figure was -$227000.0, up 80.55% from the prior year.
- Tax Provisions was -$227000.0 for Q3 2021 at Celldex Therapeutics, down from $900000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $900000.0 in Q4 2020 to a low of -$19.1 million in Q4 2017.
- Historically, Tax Provisions has averaged -$3.5 million across 4 years, with a median of -$227000.0 in 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Celldex Therapeutics | 2.16 Bn | 2.16 Bn | -1.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -227,000.00 |
| Dec 31, 2020 | 900,000.00 |
| Jun 30, 2020 | -200,000.00 |
| Jun 30, 2018 | 35,000.00 |
| Mar 31, 2018 | -800,000.00 |
| Dec 31, 2017 | -19.08 Mn |
| Sep 30, 2017 | -5.20 Mn |